SCOPUS 정보 검색 플랫폼

Volumn 88, Issue 7, 2001, Pages 659-660

Anti-tyrosine kinase: First results of initial molecular therapies of cancer diseases;L'anti-tyrosine kinase : Le début du traitement moléculaire des cancers et les premiers résultats

(1) Guilhot, F a

a POITIERS UNIVERSITY HOSPITAL (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IMATINIB; PROTEIN TYROSINE KINASE INHIBITOR;

ANTINEOPLASTIC ACTIVITY; CANCER; CHRONIC MYELOID LEUKEMIA; FRANCE; HUMAN; MEDICAL LITERATURE; MOLECULAR BIOLOGY; SARCOMA; SHORT SURVEY;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; FUSION PROTEINS, BCR-ABL; HUMANS; LEUKEMIA, MYELOID, CHRONIC; ONCOGENE PROTEINS, FUSION; PHILADELPHIA CHROMOSOME; PIPERAZINES; PROGNOSIS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES; SARCOMA; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 18744437992 PISSN: 00074551 EISSN: None Source Type: Journal
DOI: None Document Type: Short Survey

Times cited : (5)

References (7)

1
- 13044294682
- An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic mydoid leukemia: Developed for the American Society of Hematology
- (1999) Blood , vol.94 , pp. 1517-1536
- Silver, R.T.¹ Woolf, S.H.² Hehlmann, R.³ Appdbaum, F.R.⁴ Anderson, J.⁵ Bennett, C.⁶

2
- 0033987746
- Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic mydogenous leukemia
- (2000) J Clin Invest , vol.105 , pp. 3-7
- Druker, B.J.¹ Lydon, N.B.²

3
- 0035810147
- Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia
- (2001) N Engl J Med , vol.344 , pp. 1031-1037
- Druker, B.J.¹ Talpaz, M.² Resta, D.J.³ Bin Peng, R.N.⁴ Buchdunger, E.⁵ Ford, J.M.⁶

4
- 0345696854
- Interferon alpha-2b combined with cytarabine versus interferon alone in chronic mydogenous leukemia
- (1997) N Engl J Med , vol.337 , pp. 223-229
- Guilhot, F.¹ Chastang, C.² Michallet, M.³ Guerci, A.⁴ Harousseau, J.L.⁵ Maloisel, F.⁶

5
- 0035810142
- Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome
- (2001) N Engl J Med , vol.344 , pp. 1038-1042
- Druker, B.J.¹ Sawyers, C.L.² Kantarjian, H.³ Resta, D.J.⁴ Reese, S.F.⁵ Ford, J.M.⁶

6
- 0002062444
- Results of a phase II study of STI in adult patients with Philadelphia chromosome positive chronic myeloid leukemia in chronic phase (CML)
- The International STI Study Group, Novartis Pharmaceuticals Corporation, East Hanover, NJ and Basel, Switzerland, abstr. 24
- (2001) Leukemia , vol.15
- Guilhot, F.¹ Kantarjian, H.² Sawyers, C.L.³ Hochhaus, A.⁴ Schiffer, C.⁵ Resta, D.⁶

7
- 0035810148
- Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor
- (2001) N Engl J Med , vol.344 , pp. 1052-1056
- Joensuu, H.¹ Roberts, P.J.² Sarlomo-Rikala, M.³ Andersson, L.C.⁴ Tervahartiala, P.⁵ Tuveson, D.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.